News BMS adds discounted psoriasis drug to its DTC channel Bristol Myers Squibb expands its DTC sales in the US with the addition of psoriasis drug Sotyktu at an 80% discount for cash buyers.
News Lilly brings second oral SERD to market for breast cancer Lilly's Inluriyo is the second oral SERD to reach the US market for ESR1-mutated breast cancer, setting up a market tussle with Menarini's Orserdu.
News Shock as Trump says 100% pharma tariffs will start on 1 Oct After all the threats, it seems President Trump's tariffs on pharmaceuticals are coming to fruition, and a lot sooner than expected.
News Merck names electronics unit head to replace Garijo as CEO Merck KGaA's CEO Belén Garijo will step down next year and will be replaced by the group's electronics boss Kai Beckmann.
News Verona shareholders back $10bn MSD takeover MSD has moved a step closer to completing its acquisition of Verona Pharma, after a vote in favour of the transaction by the UK firm's shareholders.
News AZ takes Medicare negotiation appeal to SCOTUS AstraZeneca has elevated its challenge to Medicare drug price negotiation powers to the Supreme Court of the US.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.